课题基金 / 基金详情

Frontostriatal glutamate in ADHD: Neuropsychological and Behavioral Correlates

Frontostriatal glutamate in ADHD: Neuropsychological and Behavioral Correlates
ADHD 中的额纹状体谷氨酸:神经心理学和行为相关性
批准号:
8207969
负责人:
ALENA HORSKA
金额:
$20.29万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-01-01 至 2013-12-31

项目摘要

项目成果

ALENA HORSKA的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):拟议研究的总体目标,“ADHD中的额纹状体谷氨酸:神经心理学和行为相关性”,是利用7.0特斯拉的质子磁共振波谱研究未接受药物治疗的ADHD儿童额纹状体谷氨酸代谢的作用,并确定与这些谷氨酸以及其他神经化学异常相关的认知和行为功能障碍的具体机制。这项研究将是首次使用7.0特斯拉磁共振光谱研究儿童多动症的神经生物学。谷氨酸是一种兴奋性神经递质,是大脑中含量最多的氨基酸。它是皮质-纹状体-丘脑-皮质回路的主要兴奋性神经递质(先前通过体积磁共振成像、功能磁共振成像、静息状态功能磁共振成像和DTI研究显示ADHD异常)。谷氨酸也是基底神经节皮质纹状体传入神经的主要兴奋性神经递质,在纹状体中起着至关重要的神经调节作用,并有助于提高认知和运动功能的效率。大脑中异常的谷氨酸浓度与多种神经和精神疾病有关。在ADHD中,谷氨酸还可以调节与该疾病有关的其他神经递质的释放,包括多巴胺和血清素。来自动物模型、药理学干预、遗传和神经影像学研究的结果表明,谷氨酸神经传递增加与ADHD核心症状的发展有关。利用7.0特斯拉短回波时间下获得的单体素1H MR谱的横截面设计,结合神经心理学评估,本研究提出:1)测量5-9岁未接受药物治疗的ADHD儿童的额纹状体和顶叶谷氨酸水平(作为对照区)(与年龄、性别和社会经济地位[SES]匹配的正常发育儿童相比),强调在额叶(前额叶、前扣带)和纹状体感兴趣区域的谷氨酸,以及在所有脑区观察到的其他代谢物(NAA、Cr、Cho、mI、Gln);和;2)通过Aim 1寻找ADHD异常区域谷氨酸水平与执行功能(EF)、非EF技能和ADHD症状严重程度的行为测量之间的关系。
英文摘要
DESCRIPTION (provided by applicant): The overall goal of the proposed investigation, "Frontostriatal Glutamate in ADHD: Neuropsychological and Behavioral Correlates" is to investigate the role of frontostriatal glutamatergic metabolism in medication-naive children with ADHD using proton magnetic resonance spectroscopy at 7.0 Tesla, and to determine the specific mechanisms of cognitive and behavioral dysfunction associated with these glutamatergic as well as other neurochemical anomalies. This study will be the first investigation of the neurobiology of ADHD in children using MR spectroscopy at 7.0 Tesla. Glutamate is an excitatory neurotransmitter and the most abundant amino acid in the brain. It is the primary excitatory neurotransmitter for the cortico-striato-thalamo-cortical loop (previously shown to abnormal in ADHD via volumetric MRI, fMRI, resting state fMRI, and DTI studies). Glutamate is also the primary excitatory neurotransmitter for the cortico-striatal afferents to the basal ganglia-playing a crucial neuromodulatory role in the striatum, and contributing to efficiency of both cognitive and motor function. Abnormal glutamate concentrations in the brain have been linked to a variety of neurological and psychiatric disorders. In ADHD, glutamate also serves to modulate the release of other neurotransmitters implicated in the disorder, including dopamine and serotonin. Converging findings from animal models, pharmacologic interventions, genetic and neuroimaging studies have identified increased glutamate neurotransmission in the development of core symptoms of ADHD. Using a cross sectional design of single voxel 1H MR spectroscopy obtained with short-echo time at 7.0 Tesla, along with neuropsychological assessment, the current study proposes to: 1) measure frontostriatal and (as a control region) parietal glutamate levels in medication-naove children with ADHD, ages 5-9 years (compared to age- sex- and socioeconomic status [SES]-matched typically developing children), emphasizing glutamate in frontal (prefrontal, anterior cingulate), and striatal regions of interest, as well as other metabolites observed in the spectrum (NAA, Cr, Cho, mI, Gln) in all brain regions; and; 2) search for relationships among glutamate levels in regions identified as abnormal in ADHD via Aim 1, and behavioral measures of executive function (EF), non-EF skills, and severity of ADHD symptoms. PUBLIC HEALTH RELEVANCE: Glutamate is an excitatory amino acid and the most abundant neurotransmitter in the brain. Glutamate levels are linked to a variety of neurological and psychiatric disorders, and have been implicated in the development of core symptoms of Attention Deficit Hyperactivity Disorder (ADHD). Prior neuroimaging studies examining glutamate levels in ADHD had limited success, because at field strengths less than 2.0 Tesla, it is difficult to measure the absolute levels of glutamate in the human brain. The overall goal of the proposed investigation is to investigate the role of frontostriatal glutamatergic metabolism in medication-naive children with ADHD using proton magnetic resonance spectroscopy at 7.0 Tesla, and to determine the specific mechanisms of cognitive and behavioral dysfunction associated with these glutamatergic as well as other neurochemical anomalies. This study will be the first investigation of the neurobiology of ADHD in children using MR spectroscopy at 7.0 Tesla.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Frontostriatal glutamate in ADHD: Neuropsychological and Behavioral Correlates
METABOLIC EFFECTS OF BRAIN RADIATION IN CHILDREN
  • 批准号:
    7604579
  • 项目类别:
  • 资助金额:
    $0.29万
  • 财政年份:
    2006
  • 负责人:
    ALENA HORSKA
  • 依托单位:
METABOLIC EFFECTS OF BRAIN RADIATION IN CHILDREN
  • 批准号:
    7378851
  • 项目类别:
  • 资助金额:
    $1.29万
  • 财政年份:
    2005
  • 负责人:
    ALENA HORSKA
  • 依托单位:
METABOLIC EFFECTS OF BRAIN RADIATION IN CHILDREN
  • 批准号:
    7200773
  • 项目类别:
  • 资助金额:
    $0.52万
  • 财政年份:
    2005
  • 负责人:
    ALENA HORSKA
  • 依托单位:
海外基金